Vir Biotechnology's total assets for Q3 2025 were $1.02B, a decrease of -14.51% from the previous quarter. VIR total liabilities were $223.35M for the fiscal quarter, a -8.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.